Aerocrine Announces Leadership Changes

Aerocrine Announces Leadership Changes

Solna (Sweden), June 12 2014 — Aerocrine AB (OMX Nordic Exchange: AERO) today announced that Marshall Woodworth will be appointed new Chief Financial Officer. Anders Murman will be promoted to Chief Technology Officer. 

Suggested Articles

Former Ipsen and Novartis exec Harout Semerjian has been tapped as the latest chief executive of troubled Immunomedics.

A COVID-19 vaccine developed by a Mass General spinoff is among the candidates emerging from partnerships between tech developers and bio researchers.

Vir and GlaxoSmithKline will pool their resources to develop vaccines and treatments for coronaviruses, starting with two antibodies against COVID-19.